Article
Anti-EGF Receptor-Based Conversion Chemotherapy in RAS Wild-Type Colorectal Cancer Patients: Impact on Survival and Resection Rates.
Digestion - 1 Jan 2018
Koch Christine, Schmidt Niklas, Winkelmann Ria, Eichler Katrin, Pession Ursula, Bechstein Wolf Otto, Zeuzem Stefan, Waidmann Oliver, Trojan Jörg
Abstract excerpt
BACKGROUND: Initially unresectable colorectal liver metastases can become resectable after chemotherapy. Combination chemotherapy with epidermal growth factor receptor (EGFR) antibodies has shown consistent high response rates in patients with all rat sarcoma (RAS) wild-type tumors. METHODS: Out of a cohort of 424 patients with metastatic colorectal cancer, we identified 30 patients with initially unresectable...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
